Industry leaders share their expectations from Budget 2025-26
Experts aim for the budget to include benefits for the Nutraceuticals sector, incentives for CROs and expansion of the PLI scheme…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Parexel India
The 2025 outlook for India’s clinical trials industry
Sanjay Vyas, President and Managing Director, Parexel India, highlights that as India strengthens its position in global…
Parexel releases 2023 Environmental, Social and Governance report
The report outlines Parexel’s advancements in sustainable practices, diversity, patient engagement, and operational integrity
Pharma sector awaits Budget 2024 for innovation boost and regulatory reforms
Industry leaders highlight priorities ahead of Union Budget, calling for R&D incentives and reduced GST to propel growth and…